Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) pre-open: What am I doing today – sitting and watching!

August 28, 2018 7:54am

As I stated, “I’m staying with the herd mentality, until late Tuesday, early Wednesday, definitely by Thursday and unquestionably by Friday.”

In compiling my indication signals, I draw on logic, historical precedents, specific knowledge of the sector and its practices as to lessons learned. It’s important for investors to identify and determine which indication is actual performance based.

I answer one question, in which company should investors put, keep and commit their money

U.S. stock index futures are set for a lukewarm open

Dow futures are UP +0.10% (+27 points) and NASDAQ futures are UP +0.19% (+15 points)

U.S. stock index futures fluctuated ahead of Tuesday's open, as investors kept an eye on news coming out of the political space.

Markets in Asia and Europe tried for gains, digesting news that the U.S. and Mexico had secured a new trade deal on Monday, which would look to replace NAFTA; an accord that currently includes both countries and Canada.

Data docket: At 8:30 a.m. ET, advance economic indicators will be released, followed by the S&P/Case-Shiller House Price Index at 9 a.m. ET. Meantime at 10 a.m. ET, consumer confidence and the Richmond Fed survey of manufacturing activity are scheduled to come out, followed by the Dallas Fed's Texas Service Sector Outlook survey at 10:30 a.m. ET.

Today’s indications:

The iShares Nasdaq Biotechnology (IBB) is NOT indicating in Tuesday’s pre-market;

The SPDR S&P Biotech ETF (XBI) is NOT indicating a in Tuesday’s pre-market;

The Health Care Select Sector SPDR ETF (XLV) is indicating a -0.05% DOWNSIDE in Tuesday’s pre-open;

The iShares Russell 2000 (IWM) is indicating a +0.9% UPSIDE in Tuesday’s pre-open

Henry’omics:

I am NOT thinking today ... I couldn't even get the take-out coffee orders correct for the guests and the "babe" made me return to the "scene" to get a "black" coffee - it's early! No reverers, the dogs are being walked and the few "up" risers are walking and running.

I always want to know what happened PRIOR to what might happen today – it sets a tone of consequence:

From Monday’s night’s newsletter: “I’m staying with the herd mentality until late Wednesday, early Thursday and definitely by Friday.”

The iShares NASDAQ Biotechnology (IBB):

Monday closed up +1.75%
Friday closed up +0.17%;
Thursday’s -0.58%
Wednesday’s +0.71%,
Last Tuesday’s +0.93%
For a five session aggregate of +2.98% - looking at the start of a downside reaction!

Of the 45 companies covered on Monday; 7 downside equities finished in a range of -1.32% (KOOL) to -9.59% (BSTG) while the 35 upside equities oscillated from +0.19% (VYGR) to +16.23% (ALNY) with 3 flat closes (AST, ONVO and FATE).

August’s measurement:

Of the past 5 sessions – 5 had closed positive with zero negative close,
Of the past 10 sessions – 3 had closed negative
Of the 18 August sessions – 6 had negative and 13 positive closes

Companies in my headlights – It’s your decision; I provide the idea and context:

…. Everyone deserves a vacation – dune buggying today!

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.